Dechra Pharmaceuticals (DPH)

Sector:

Pharma and Biotech

Index:

FTSE 100

4,120.00p
   
  • Change Today:
    -106.00p
  • 52 Week High: 5,405.00
  • 52 Week Low: 3,272.00
  • Currency: UK Pounds
  • Shares Issued: 108.36m
  • Volume: 224,423
  • Market Cap: £4,464.63m
  • RiskGrade: 121

Latest ShareCast News

Dechra sees full year at upper end of management expectations

By Michele Maatouk

Date: Thursday 13 Jan 2022

(Sharecast News) - Dechra Pharmaceuticals said on Thursday that the full-year outlook was towards the upper end of management expectations as it reported a jump in first-half revenues.

Dechra acquires worldwide rights to canine lymphoma treatment

By Iain Gilbert

Date: Wednesday 12 Jan 2022

(Sharecast News) - Pharmaceutical giant Dechra has acquired the worldwide rights to verdinexor, a novel treatment of all forms and stages of canine lymphoma from Anivive Lifesciences.

Dechra slumps as Exane highlights 'punchy valuation'

By Michele Maatouk

Date: Tuesday 04 Jan 2022

(Sharecast News) - Dechra Pharmaceuticals was under the cosh on Tuesday after Exane BNP Paribas initiated coverage of the stock at 'neutral' on valuation grounds.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

DPH Market Data

Currency UK Pounds
Share Price 4,120.00p
Change Today -106.00p
% Change -2.51 %
52 Week High 5,405.00
52 Week Low 3,272.00
Volume 224,423
Shares Issued 108.36m
Market Cap £4,464.63m
RiskGrade 121

DPH Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
99.1% below the market average99.1% below the market average99.1% below the market average99.1% below the market average99.1% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
19.71% above the market average19.71% above the market average19.71% above the market average19.71% above the market average19.71% above the market average
22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average22.58% above the sector average
Income
84.24% below the market average84.24% below the market average84.24% below the market average84.24% below the market average84.24% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average
Growth
82.67% above the market average82.67% above the market average82.67% above the market average82.67% above the market average82.67% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 5
Sell 0
Strong Sell 1
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

DPH Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Oct-21 04-Mar-21
Paid 19-Nov-21 07-Apr-21
Amount 29.39p 11.11p

Trades for 18-Jan-2022

Time Volume / Share Price
16:35 29,332 @ 4,112.06p
16:35 97,224 @ 4,120.00p
16:29 57 @ 4,098.00p
16:29 2 @ 4,098.00p
16:27 90 @ 4,100.00p

DPH Key Personnel

CEO Ian Page
CFO Paul Sandland

Top of Page